Target
Interleukin-1 receptor-associated kinase 4
Ligand
BDBM283821
Substrate
n/a
Meas. Tech.
Inhibition Assay
IC50
5.20±n/a nM
Citation
 Bhide, RSDuncia, JVHynes, JNair, SKPitts, WJKumar, SRGardner, DSMurugesan, NPaidi, VRSantella, JBSistla, RWu, H Heteroaryl substituted pyridyl compounds useful as kinase modulators US Patent  US9657009 Publication Date 5/23/2017 
Target
Name:
Interleukin-1 receptor-associated kinase 4
Synonyms:
IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64
Type:
Protein
Mol. Mass.:
51519.08
Organism:
Homo sapiens (Human)
Description:
Q9NWZ3
Residue:
460
Sequence:
MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS
  
Inhibitor
Name:
BDBM283821
Synonyms:
US10023562, Example 15 | US10544133, Example 15 | US9657009, 15
Type:
Small organic molecule
Emp. Form.:
C23H28ClN7O2
Mol. Mass.:
469.967
SMILES:
CC(C)Nc1cc(Nc2ncc(cc2Cl)C#N)ncc1C(=O)N[C@H]1CC[C@@H](CC1)NC(C)=O |r,wU:26.31,wD:23.24,(2.67,3.47,;2.67,1.93,;4,1.16,;1.33,1.15,;1.33,-.38,;2.67,-1.15,;2.67,-2.69,;4,-3.47,;5.33,-2.69,;6.67,-3.47,;8,-2.69,;8.05,-1.13,;6.67,-.38,;5.33,-1.15,;4,-.38,;9.38,-.36,;10.72,.41,;1.33,-3.47,;,-2.69,;,-1.15,;-1.33,-.38,;-1.33,1.15,;-2.67,-1.15,;-4,-.38,;-4,1.15,;-5.33,1.93,;-6.67,1.15,;-6.67,-.38,;-5.33,-1.15,;-8,1.93,;-9.34,1.15,;-10.67,1.93,;-9.34,-.38,)|
Structure:
Search PDB for entries with ligand similarity: